billHR6364Event Tuesday, December 2, 2025Analyzed

Kidd’s Stuttering Act

Bullish

Summary

HR6364 (Kidd's Stuttering Act) mandates Medicaid and CHIP coverage for childhood stuttering screening and speech therapy, creating a new, guaranteed revenue stream for managed care organizations and speech therapy providers. The bill is in early stage (referred to committee) with 12 cosponsors. Real market data shows UNH, ELV, and HUM all up 32-46% in the last 30 days, though this is likely driven by broader sector momentum rather than this specific bill at this stage.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR6364 mandates Medicaid/CHIP coverage for childhood stuttering screening and speech therapy — creates guaranteed new revenue for managed care plans, not a one-time appropriation.
  • 2.No explicit funding amount is specified; costs flow through existing mandatory Medicaid entitlement via capitation rate adjustments.
  • 3.UNH and ELV are the most leveraged large-cap MCOs; HUM has smaller but additive exposure.
  • 4.Bill is early stage (referred to committee, 12 cosponsors) — passage probability is uncertain but structure is bullish if it advances.
  • 5.Real market data shows MCO stocks up 32-46% in 30 days but driven by broader factors, not this specific bill.

Market Implications

The Kidd's Stuttering Act is a structurally bullish, incremental tailwind for the three largest Medicaid MCOs — UNH, ELV, and HUM — but at the bill's current early stage (referred to committee, no markup), the market impact is negligible compared to larger sector drivers. The real price action over the past 30 days (UNH +41.62%, ELV +32.25%, HUM +46.46%) reflects broader managed care sector momentum including Medicare Advantage rate finalization and Q1 2026 earnings beats. Investors should monitor committee markup as the first signal of legislative viability. If the bill advances to a House floor vote, expect a 1-2% incremental move in MCO stocks as the market prices in the new guaranteed revenue stream.

Full Analysis

  1. On December 2, 2025, Rep. McDowell (R-NC) introduced HR6364, the Kidd's Stuttering Act, which was referred to the House Committee on Energy and Commerce. The bill is at an early stage with 12 cosponsors and no committee markup yet. It amends the Social Security Act to require screenings for childhood-onset fluency disorders (stuttering) in Medicaid and CHIP well-child visits for children aged 2-5, and mandates coverage of speech therapy services.

  2. The money trail: The bill does NOT appropriate any specific dollar amount. It is an authorization of a mandatory coverage requirement under Medicaid and CHIP, meaning it uses the existing entitlement structure. The funding flows through CMS adjustments to state Medicaid capitation rates for managed care plans. States will increase per-member per-month (PMPM) payments to MCOs to account for the new mandated services. The total cost to the federal government is not specified in the bill text but will be absorbed by the existing Medicaid entitlement — no separate appropriation is needed for mandatory coverage expansions of this type.

  3. Structural winners: The primary beneficiaries are Medicaid managed care organizations — UNH (UnitedHealthcare, largest Medicaid MCO), ELV (Elevance Health, second-largest), and HUM (Humana, growing Medicaid presence). Speech therapy providers (both independent practitioners and corporate chains) will see increased patient volume. CVS Health (CVS) has a smaller Medicaid MCO business (Aetna Better Health) but is less directly leveraged to this specific mandate. The bill does not affect commercial insurance or Medicare Advantage.

  4. Real market data from Yahoo Finance shows strong recent performance: UNH at $370.74 (+4.56% 7-day, +41.62% 30-day), ELV at $376.63 (+8.76% 7-day, +32.25% 30-day), HUM at $243.12 (+13.11% 7-day, +46.46% 30-day). These moves are likely driven by broader sector catalysts (Medicare Advantage rate finalization, earnings momentum) rather than this early-stage bill, but the Kidd's Stuttering Act represents a structurally bullish tailwind if it advances.

  5. Timeline: The bill is in early stages. The next steps are: committee markup in Energy and Commerce, House floor vote, Senate introduction (no companion bill yet), Senate committee, Senate floor vote, and Presidential signature. With a Republican sponsor in a Republican-controlled House (119th Congress), committee attention is possible but not guaranteed. The January 1, 2027 effective date for the screening mandate is two years out, giving Congress time to pass the bill.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Moderate

Some confirming evidence found across public data sources

Confirmed by:
$$UNH▲ Bullish
Est. $50.0M$200.0M revenue impact

What the bill does

Mandate: The bill requires Medicaid and CHIP plans to cover screenings for childhood-onset fluency disorders and speech therapy services as part of well-child visits, beginning January 1, 2027.

Who must act

State Medicaid agencies and the managed care organizations (MCOs) contracting with them, including UnitedHealthcare's Medicaid plans.

What happens

Creates a guaranteed increase in covered service volume for speech therapy and diagnostic screenings, adding a new revenue stream per covered child aged 2-5. Medicaid managed care capitation rates will be adjusted upward by CMS to reflect the new required services.

Stock impact

UnitedHealthcare is the largest Medicaid managed care organization in the U.S., covering over 7 million Medicaid beneficiaries. The mandate directly increases per-member service utilization and associated capitation payments for a previously uncovered service category. No new competitor entry is required.

$$ELV▲ Bullish
Est. $30.0M$150.0M revenue impact

What the bill does

Mandate: The bill requires Medicaid and CHIP plans to cover screenings for childhood-onset fluency disorders and speech therapy services as part of well-child visits, beginning January 1, 2027.

Who must act

State Medicaid agencies and their contracted MCOs, including Elevance Health's Anthem Blue Cross Blue Shield Medicaid plans.

What happens

Creates a guaranteed increase in covered service volume for speech therapy and diagnostic screenings for children aged 2-5 enrolled in Medicaid/CHIP. Capitation payments will be adjusted upward by CMS to cover the new mandated services.

Stock impact

Elevance Health is the second-largest Medicaid managed care organization in the U.S., with over 5 million Medicaid members across multiple states. The mandate directly adds a new billable service category per member, with per-member capitation adjustments flowing through to revenue. No capital expenditure or competitive risk is tied to this mandate.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 25, 2026

Advancing Regenerative Agriculture and Strengthening American Farm Resilience

This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Exec OrderMay 29, 2026

Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →